Pivotal Therapeutics Inc. announced earnings results for the nine months ended September 30, 2015. For the period, the company reported an increase in sales of 88% to CAD 373,787 from CAD 198,867 in 2014. The company reported a decrease of 32% in net loss to CAD 3,706,876 from CAD 5,418,497 in 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0018 USD | +179,900.00% | -.--% | -.--% |
2016 | Pivotal Therapeutics Inc. Announces Management Changes | CI |
2015 | Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 172K | |
+21.80% | 43.81B | |
+30.40% | 23.03B | |
+21.32% | 15.45B | |
+19.05% | 14.4B | |
+58.92% | 12.95B | |
-0.05% | 6.79B | |
-11.84% | 6.49B | |
-8.87% | 5.73B | |
+13.00% | 5.49B |
- Stock Market
- Equities
- PVTTF Stock
- News Pivotal Therapeutics Inc.
- Pivotal Therapeutics Inc. Announces Earnings Results for the Nine Months Ended September 30, 2015